Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Piotr Adamowicz. (2021) Blood concentrations of synthetic cannabinoids. Clinical Toxicology 59:3, pages 246-251.
Read now
Read now
Maren Hermanns-Clausen, Dieter Müller, Josephine Kithinji, Verena Angerer, Florian Franz, Florian Eyer, Hartmud Neurath, Gesine Liebetrau & Volker Auwärter. (2018) Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA. Clinical Toxicology 56:6, pages 404-411.
Read now
Read now
Chitra Meyyappan, Loretta Ford & Allister Vale. (2017) Poisoning due to MDMB-CHMICA, a synthetic cannabinoid receptor agonist. Clinical Toxicology 55:2, pages 151-152.
Read now
Read now
Articles from other publishers (23)
Mariana Campello de Oliveira, Mariana Capelo Vides, Dângela Layne Silva Lassi, Julio Torales, Antonio Ventriglio, Henrique Silva Bombana, Vilma Leyton, Cintia de Azevedo-Marques Périco, André Brooking Negrão, André Malbergier & João Maurício Castaldelli-Maia. (2023) Toxicity of Synthetic Cannabinoids in K2/Spice: A Systematic Review. Brain Sciences 13:7, pages 990.
Crossref
Crossref
Arianna Giorgetti, Vasco Orazietti, Francesco Paolo Busardò & Raffaele Giorgetti. (2023) Psychomotor performances relevant for driving under the combined effect of ethanol and synthetic cannabinoids: A systematic review. Frontiers in Psychiatry 14.
Crossref
Crossref
Alice Seywright, Alexander F. D Irvine, Denise A McKeown, Fiona M Wylie & Hazel J Torrance. (2022) Synthetic Cannabinoid Receptor Agonists in Postmortem Casework in Scotland. Journal of Analytical Toxicology 46:9, pages 1066-1072.
Crossref
Crossref
Elisabet Navarro-Tapia, Jana Codina, Víctor José Villanueva-Blasco, Óscar García-Algar & Vicente Andreu-Fernández. (2022) Detection of the Synthetic Cannabinoids AB-CHMINACA, ADB-CHMINACA, MDMB-CHMICA, and 5F-MDMB-PINACA in Biological Matrices: A Systematic Review. Biology 11:5, pages 796.
Crossref
Crossref
Grant C. Glatfelter, John S. Partilla & Michael H. Baumann. (2021) Structure-activity relationships for 5F-MDMB-PICA and its 5F-pentylindole analogs to induce cannabinoid-like effects in mice. Neuropsychopharmacology 47:4, pages 924-932.
Crossref
Crossref
Carolina Belenguer-Sapiña, Roberto Sáez-Hernández, Enric Pellicer-Castell, Sergio Armenta & Adela.R. Mauri-Aucejo. (2022) Simultaneous determination of third-generation synthetic cannabinoids in oral fluids using cyclodextrin-silica porous sorbents. Microchemical Journal 172, pages 106915.
Crossref
Crossref
Alex J. Krotulski, Nancy Garibay, Donna Walther, Sara E. Walton, Amanda L.A. Mohr, Barry K. Logan & Michael H. Baumann. (2021) Pharmacokinetics and pharmacodynamics of the synthetic cannabinoid, 5F-MDMB-PICA, in male rats. Neuropharmacology 199, pages 108800.
Crossref
Crossref
Phoebe Sharp, Simon Hudson & Stephen R. Morley. (2021) Quantitation of Synthetic Cannabinoid Receptor Agonists in Postmortem Blood Using a Single Point Calibration. Academic Forensic Pathology 11:2, pages 75-82.
Crossref
Crossref
Arianna Giorgetti, Francesco Paolo Busardò, Roberta Tittarelli, Volker Auwärter & Raffaele Giorgetti. (2020) Post-Mortem Toxicology: A Systematic Review of Death Cases Involving Synthetic Cannabinoid Receptor Agonists. Frontiers in Psychiatry 11.
Crossref
Crossref
Sean D. McCann & Sean M. Bryant. (2019) ADB-FUBINACA Body Packer. The Journal of Emergency Medicine 57:3, pages 397.
Crossref
Crossref
Elise Wouters, Lukas Mogler, Annelies Cannaert, Volker Auwärter & Christophe Stove. (2019)
Functional evaluation of carboxy metabolites of synthetic cannabinoid receptor agonists featuring scaffolds based on L‐valine or L‐
tert
‐leucine
. Drug Testing and Analysis 11:8, pages 1183-1191.
Crossref
Crossref
Franziska Gaunitz, Sabrina Lehmann, Andreas Thomas, Mario Thevis, Markus A. Rothschild & Katja Mercer-Chalmers-Bender. (2018) Correction to: Post-mortem distribution of the synthetic cannabinoid MDMB-CHMICA and its metabolites in a case of combined drug intoxication. International Journal of Legal Medicine 133:3, pages 973-973.
Crossref
Crossref
Nicholas Nacca, Rachel Schult, Robert Loflin, Adam Weltler, Rachel Gorodetsky, Sherri Kacinko, Jeffery Moran, Alex Krotulski & Timothy Wiegand. (2018) Coma, Seizures, Atrioventricular Block, and Hypoglycemia in an ADB-FUBINACA Body-Packer. The Journal of Emergency Medicine 55:6, pages 788-791.
Crossref
Crossref
Franziska Gaunitz, Sabrina Lehmann, Andreas Thomas, Mario Thevis, Markus A. Rothschild & Katja Mercer-Chalmers-Bender. (2018) Post-mortem distribution of the synthetic cannabinoid MDMB-CHMICA and its metabolites in a case of combined drug intoxication. International Journal of Legal Medicine 132:6, pages 1645-1657.
Crossref
Crossref
Hideyuki Maeda, Erika Nagashima, Yukiko K. Hayashi, Ruri Kikura-Hanajiri & Ken-ichi Yoshida. (2018) MDMB-CHMICA induces thrashing behavior, bradycardia, and slow pressor response in a CB1- and CB2-receptor-dependent manner in conscious rats. Forensic Toxicology 36:2, pages 313-319.
Crossref
Crossref
Simon L Hill, Michael Dunn, Céline Cano, Suzannah J Harnor, Ian R Hardcastle, Johann Grundlingh, Paul I Dargan, David M Wood, Simon Tucker, Thomas Bartram & Simon H L Thomas. (2018) Human Toxicity Caused by Indole and Indazole Carboxylate Synthetic Cannabinoid Receptor Agonists: From Horizon Scanning to Notification. Clinical Chemistry 64:2, pages 346-354.
Crossref
Crossref
Thomas GeschwindeThomas Geschwinde. 2018. Rauschdrogen. Rauschdrogen
1
392
.
Matthew Valento & Jacob Lebin. (2017) Emerging Drugs of Abuse: Synthetic Cannabinoids, Phenylethylamines (2C Drugs), and Synthetic Cathinones. Clinical Pediatric Emergency Medicine 18:3, pages 203-211.
Crossref
Crossref
Noreen D Mdege, Nick Meader, Charlie Lloyd, Steve Parrott & Jim McCambridge. (2017) The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations. Public Health Research 5:4, pages 1-138.
Crossref
Crossref
Florian Franz, Verena Angerer, Bjoern Moosmann & Volker Auwärter. (2017) Phase I metabolism of the highly potent synthetic cannabinoid MDMB-CHMICA and detection in human urine samples. Drug Testing and Analysis 9:5, pages 744-753.
Crossref
Crossref
Martijn D.P. Risseeuw, Peter Blanckaert, Vera Coopman, Stijn Van Quekelberghe, Serge Van Calenbergh & Jan Cordonnier. (2017) Identification of a new tert -leucinate class synthetic cannabinoid in powder and “spice-like” herbal incenses: Methyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate (5F-MDMB-PICA). Forensic Science International 273, pages 45-52.
Crossref
Crossref
Matilda Bäckberg, Luiza Tworek, Olof Beck & Anders Helander. (2016) Analytically Confirmed Intoxications Involving MDMB-CHMICA from the STRIDA Project. Journal of Medical Toxicology 13:1, pages 52-60.
Crossref
Crossref
. (2016) Diazepam/morphine/nordazepam. Reactions Weekly 1619:1, pages 86-86.
Crossref
Crossref